Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 6

Filters

Palmitoylethanolamide manufacturers

6 products found

Filters

6 products found

palmitoylethanolamide + sichuan pepper + vitamin b1 + vitamin b6 + vitamin b12

Capsules 400 mg + 250 mg + 13 mg + 4.8 mg + 10 mcg

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Nervous system support
Product description
Food supplement with palmitoylethanolamide (PEA), zanthoxylum bungeanum, vitamins B1, B6 and B12 which contribute to the normal functioning of the nervous system.
Manufacturer #28078

Manufacturer usually replies in 1 days

palmitoylethanolamide

Oral solution 100 mg/5 ml - 250 ml

Country of origin
European Union
Recommended use
Nervous system support
Product description
Liposomal PEA CureSupport antioxidant: vitamin E (as d-alpha tocopherol).
Manufacturer #24582

Manufacturer usually replies in 6 days

palmitoylethanolamide + boswellia

Tablets, modified release (MR)

Country of origin
European Union
Recommended use
Joint supplements, Bone health
Product description
Counters inflammation and supports the well-being of bones and joints. Product based on Palmitoylethanolamide (PEA) and extract of Boswellia. Extract of Boswellia with a high content of Boswellic acids. Ideal for countering acute or chronic inflammation of bones and joints.
Manufacturer #26801

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation